Mol Neurobiol:新研究为对抗恶性脑瘤提供新希望

2016-09-28 佚名 生物谷

英国南安普敦大学的研究人员最近发现一种阻止胶质母细胞瘤扩散的新方法。胶质母细胞瘤是成年人中最常见并且最具侵袭性的一种恶性脑瘤,这种疾病具有生长快速易于扩散的特点。胶质母细胞瘤细胞会向脑的其他部分延伸,导致想要将其彻底移除变得非常困难。 虽然科学家们已经在白血病和其他一些癌症治疗方面取得了巨大进展,但是对于胶质母细胞瘤如何形成以及肿瘤细胞如何侵入脑组织仍然了解较少。 在这篇发表在国际学术


英国南安普敦大学的研究人员最近发现一种阻止胶质母细胞瘤扩散的新方法。胶质母细胞瘤是成年人中最常见并且最具侵袭性的一种恶性脑瘤,这种疾病具有生长快速易于扩散的特点。胶质母细胞瘤细胞会向脑的其他部分延伸,导致想要将其彻底移除变得非常困难。

虽然科学家们已经在白血病和其他一些癌症治疗方面取得了巨大进展,但是对于胶质母细胞瘤如何形成以及肿瘤细胞如何侵入脑组织仍然了解较少。

在这篇发表在国际学术期刊Molecular Neurobiology上的文章中,Dr. Elodie Siney在Dr. Sandrine Willaime-Morawek的指导下,对一类叫做ADAM的酶进行了分析,研究这类酶如何影响人类肿瘤细胞的运动和功能。

研究结果表明如果能够阻断ADAM10和ADAM17这两个酶的作用,肿瘤细胞就会停止生长和迁移,甚至可以通过传统的癌症治疗方法,包括放疗、化疗和手术将癌细胞从生长位置清除。

研究人员表示:“如果这些结果能够在胶质母细胞瘤的动物模型上得到证实,这项发现将对病人和医生来说变得特别重要。胶质母细胞瘤是一种灾难性疾病,通常不可治愈。我们发现阻断ADAM的作用有望抑制肿瘤生长降低传统治疗之后的复发风险,提高手术完全移除肿瘤的机会,提高病人生存率。”

原始出处:

Elodie J. Siney, Alexander Holden, Elizabeth Casselden, Harry Bulstrode, Gareth J. Thomas, Sandrine Willaime-Morawek.Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells.Molecular Neurobiology DOI: 10.1007/s12035-016-0053-6


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2055904, encodeId=78602055904ea, content=<a href='/topic/show?id=a8e1529484f' target=_blank style='color:#2F92EE;'>#恶性脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52948, encryptionId=a8e1529484f, topicName=恶性脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Tue Feb 14 08:48:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969932, encodeId=cdfe196993223, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58340, encryptionId=ec345834075, topicName=新希望)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d7319, createdName=珙桐, createdTime=Tue Jul 18 06:48:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917333, encodeId=d2ea191e333c8, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Jan 04 07:48:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767045, encodeId=adba1e67045a9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Wed Jul 05 14:48:00 CST 2017, time=2017-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275676, encodeId=2ea512e567696, content=<a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84946, encryptionId=aad38494640, topicName=脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Sep 30 12:48:00 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2055904, encodeId=78602055904ea, content=<a href='/topic/show?id=a8e1529484f' target=_blank style='color:#2F92EE;'>#恶性脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52948, encryptionId=a8e1529484f, topicName=恶性脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Tue Feb 14 08:48:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969932, encodeId=cdfe196993223, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58340, encryptionId=ec345834075, topicName=新希望)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d7319, createdName=珙桐, createdTime=Tue Jul 18 06:48:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917333, encodeId=d2ea191e333c8, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Jan 04 07:48:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767045, encodeId=adba1e67045a9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Wed Jul 05 14:48:00 CST 2017, time=2017-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275676, encodeId=2ea512e567696, content=<a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84946, encryptionId=aad38494640, topicName=脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Sep 30 12:48:00 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
    2017-07-18 珙桐
  3. [GetPortalCommentsPageByObjectIdResponse(id=2055904, encodeId=78602055904ea, content=<a href='/topic/show?id=a8e1529484f' target=_blank style='color:#2F92EE;'>#恶性脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52948, encryptionId=a8e1529484f, topicName=恶性脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Tue Feb 14 08:48:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969932, encodeId=cdfe196993223, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58340, encryptionId=ec345834075, topicName=新希望)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d7319, createdName=珙桐, createdTime=Tue Jul 18 06:48:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917333, encodeId=d2ea191e333c8, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Jan 04 07:48:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767045, encodeId=adba1e67045a9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Wed Jul 05 14:48:00 CST 2017, time=2017-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275676, encodeId=2ea512e567696, content=<a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84946, encryptionId=aad38494640, topicName=脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Sep 30 12:48:00 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
    2017-01-04 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=2055904, encodeId=78602055904ea, content=<a href='/topic/show?id=a8e1529484f' target=_blank style='color:#2F92EE;'>#恶性脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52948, encryptionId=a8e1529484f, topicName=恶性脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Tue Feb 14 08:48:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969932, encodeId=cdfe196993223, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58340, encryptionId=ec345834075, topicName=新希望)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d7319, createdName=珙桐, createdTime=Tue Jul 18 06:48:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917333, encodeId=d2ea191e333c8, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Jan 04 07:48:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767045, encodeId=adba1e67045a9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Wed Jul 05 14:48:00 CST 2017, time=2017-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275676, encodeId=2ea512e567696, content=<a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84946, encryptionId=aad38494640, topicName=脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Sep 30 12:48:00 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2055904, encodeId=78602055904ea, content=<a href='/topic/show?id=a8e1529484f' target=_blank style='color:#2F92EE;'>#恶性脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52948, encryptionId=a8e1529484f, topicName=恶性脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Tue Feb 14 08:48:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969932, encodeId=cdfe196993223, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58340, encryptionId=ec345834075, topicName=新希望)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d7319, createdName=珙桐, createdTime=Tue Jul 18 06:48:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917333, encodeId=d2ea191e333c8, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Jan 04 07:48:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767045, encodeId=adba1e67045a9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Wed Jul 05 14:48:00 CST 2017, time=2017-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275676, encodeId=2ea512e567696, content=<a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84946, encryptionId=aad38494640, topicName=脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Sep 30 12:48:00 CST 2016, time=2016-09-30, status=1, ipAttribution=)]
    2016-09-30 jxrzshh

相关资讯

盘点:脑瘤2016重要研究进展

脑癌是指生长在颅腔的新生物,又称颅内肿瘤、脑瘤,可起源于脑、脑膜、神经、血管及脑附件,或由身体的其他组织或脏器转移侵入颅内而形成,大都可产生头痛、颅内高压及局灶性症状。近年来,颅内肿瘤发病率呈上升趋势,颅内肿瘤约占全身肿瘤的5%,占儿童肿瘤的70%。恶性胶质瘤,源自神经上皮的肿瘤统称为胶质瘤(胶质细胞瘤),占颅脑肿瘤的40-50%,是最常见的颅内恶性肿瘤。在英国,每年有1.6万多人经诊断患

基因改造病毒治疗脑胶质瘤进入临床试验I期阶段

恶性胶质瘤,最常见的颅内恶性肿瘤 脑癌是指生长在颅腔的新生物,又称颅内肿瘤、脑瘤,可起源于脑、脑膜、神经、血管及脑附件,或由身体的其他组织或脏器转移侵入颅内而形成,大都可产生头痛、颅内高压及局灶性症状。 近年来,颅内肿瘤发病率呈上升趋势,颅内肿瘤约占全身肿瘤的5%,占儿童肿瘤的70%。恶性胶质瘤,源自神经上皮的肿瘤统称为胶质瘤(胶质细胞瘤),占颅脑肿瘤的40-50%,是最常见的颅内恶性

J Epidemiol Community Health:学历越高,患脑瘤风险越大?

英国伦敦大学学院和瑞典卡罗林斯卡医学院的研究人员共同进行了这项研究,他们将研究结果发表在Epidemiology & Community Health。 据美国脑部肿瘤协会的统计,大脑和中枢神经系统肿瘤从组织学角度划分共超过100种。 脑膜瘤是最常见的原发性脑肿瘤,占所有脑部原发肿瘤的36.4%。神经胶质瘤占所有脑部肿瘤的27%,占所有恶性肿瘤的80%。神经胶质瘤主要存在于周围神经胶质细胞

脑瘤治疗重大突破!液态阿司匹林杀死脑癌细胞的效率比化疗提高10倍!

昨天(2016年6月28日)在波兰首都华沙举行的“脑瘤 2016---从生物学到治疗(Brain Tumours 2016 – From Biology to Therapy)”国际研究会议上,一项潜在里程碑性的科学突破对未来的脑瘤治疗产生极其深远的影响。 依据这项突破性的研究,含有液态阿司匹林的饮料可能能够延长上千名脑癌患者的寿命。 研究人员发现这种简单的药物能够穿过血脑

脑瘤首次超过白血病,成为新的“儿童肿瘤之王”

脑肿瘤不是成年人的专利,儿童与青少年患脑瘤的几率也非常高。我国每年至少有7000~8000名儿童被查出患脑肿瘤,被认为是仅次于白血病的儿童癌症杀手。不过,美国CDC发布了最新数据显示:近年来由于白血病治疗的改善,脑瘤自2014年开始,已经超过白血病,成为新的“儿童肿瘤之王”。CDC公布:儿童死亡诱因排行榜在过去的数十年里,统计数据显示:“血癌”——白血病是儿童癌症的主要类型。然近年来,随着化疗、放

JECH:高等教育会增加患脑瘤风险

通过大量的研究表明,高程度教育会增加患脑瘤的风险,该文发表在《Journal of Epidemiology & Community Health》杂志上。数据显示,在大学学习至少3年的人比那些没有进入高等学府教育的人患神经胶质瘤的机率大。研究人员的发现是基于对超过430万瑞典人的研究分析得出的数据,这些研究对象出生在1911年和1961年之间,1991年在瑞典生活。研究人员从受教育程度,